Your browser doesn't support javascript.
loading
SARS-CoV-2 infection long time after full vaccination is related to a lack of neutralizing antibodies.
Alidjinou, Enagnon Kazali; Gaillot, Olivier; Guigon, Aurélie; Tinez, Claire; Lazrek, Mouna; Bocket, Laurence; Engelmann, Ilka; Hober, Didier.
Afiliação
  • Alidjinou EK; Univ Lille, Faculté de Médecine, CHU Lille, Laboratoire de Virologie ULR3610, Lille, France. Electronic address: enagnonkazali.alidjinou@chru-lille.fr.
  • Gaillot O; Univ Lille, Faculté de Médecine, CHU Lille, Institut de Microbiologie, F-59000 Lille France.
  • Guigon A; Univ Lille, Faculté de Médecine, CHU Lille, Laboratoire de Virologie ULR3610, Lille, France.
  • Tinez C; Univ Lille, Faculté de Médecine, CHU Lille, Laboratoire de Virologie ULR3610, Lille, France.
  • Lazrek M; Univ Lille, Faculté de Médecine, CHU Lille, Laboratoire de Virologie ULR3610, Lille, France.
  • Bocket L; Univ Lille, Faculté de Médecine, CHU Lille, Laboratoire de Virologie ULR3610, Lille, France.
  • Engelmann I; Univ Lille, Faculté de Médecine, CHU Lille, Laboratoire de Virologie ULR3610, Lille, France.
  • Hober D; Univ Lille, Faculté de Médecine, CHU Lille, Laboratoire de Virologie ULR3610, Lille, France.
Diagn Microbiol Infect Dis ; 102(1): 115565, 2022 Jan.
Article em En | MEDLINE | ID: mdl-34731684
ABSTRACT
SARS-CoV-2 infections after COVID-19 vaccination are not unexpected, but those occurring more than 14 days after second vaccine dose need to be investigated. We describe a well-characterized infection which occurred almost 2 months after full vaccination, and provide the evidence of a link with a lack of anti-SARS-CoV-2 neutralizing antibodies.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article